pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Eli Lilly and Co

updated 2mo ago

Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.

community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval150 co-mentions · 75 sources
  • drugMOUNJARO48 co-mentions · 24 sources
  • drugZEPBOUND48 co-mentions · 24 sources
  • drugtirzepatide48 co-mentions · 24 sources
  • drugTRULICITY44 co-mentions · 22 sources
  • drugdulaglutide44 co-mentions · 22 sources
  • drugselpercatinib38 co-mentions · 19 sources
  • drugRETEVMO38 co-mentions · 19 sources
pipeline
28
marketed
18
phase 3
4
catalysts ytd
0
approvals ytd
0
recalls ytd
0

Pipeline(28)

view full pipeline →
pipeline depth28 products
Phase 2: 4Phase 3: 4Marketed: 18pre_registration: 2
4Phase 24Phase 318Marketed2pre_registration
Marketed
Abasaglar
Type 1 Diabetes (Juvenile Diabetes)
Marketed
Adcirca
Pulmonary Arterial Hypertension
Marketed
Lyumjev
Type 1 Diabetes (Juvenile Diabetes)
Marketed
Prozac
Depression
Marketed
abemaciclib
Human Epidermal Growth Factor Receptor 2 Negative Breast…
Marketed
baricitinib
Alopecia Areata
Tyrosine-protein kinase JAK1Tyrosine-protein kinase JAK2
Marketed
donanemab
Alzheimer's Disease
Marketed
dulaglutide
Cardiovascular Risk Factors
Marketed
etesevimab
Coronavirus Disease 2019 (COVID-19)
Marketed
galcanezumab
Migraine
Marketed
imlunestrant tosylate
Human Epidermal Growth Factor Receptor 2 Negative Breast…
Marketed
ixekizumab
Plaque Psoriasis (Psoriasis Vulgaris)

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →
🐶 Hiring Signal
No open roles indexed yet — view Eli Lilly and Co jobs →

News

  • MindMaze trims Relief staff, Aardvark cuts workforce amid Prader-Willi troubles
    Follow along as BioSpace tracks job cuts and restructuring initiatives.
    biospace · 16h ago
  • Bankrupt Sangamo offloads assets to Lilly, PTC in $161M sale
    PTC Therapeutics emerged as the winning bidder over Astellas for Sangamo Therapeutics’ Fabry disease gene therapy, while Eli Lilly is purchasing the biotech’s prion disease program and several plat…
    biospace · 19h ago
  • Lilly cracks down on black market for obesity asset retatrutide with six lawsuits
    Beyond the legal action, Eli Lilly is calling on healthcare providers, regulatory authorities, online platforms and even logistics companies to help stem the illegal sale of its next-generation ass…
    biospace · 1d ago
  • 7 companies hiring in North Carolina now
    Looking for a biopharma job in North Carolina? Job postings in the area have increased. Here are seven companies with open roles.
    biospace · 1d ago
  • Replimune finally wins approval, Q2 earnings wrap up, psychedelics stay in spotlight
    After two rejections, Replimune has made it across the regulatory finish line with its advanced melanoma therapy. Meanwhile, the last of the major pharmas, including Eli Lilly and Novo Nordisk, rep…
    biospace · 1d ago
  • With tech backing, AI biotechs force biopharma into ‘fail-fast’ drug development
    AI is quickly becoming a central force in drug development, from powering pharma engines to permanently rewiring the capital markets.
    biospace · 2d ago
  • Amgen lays groundwork for new R&D center in Hyderabad
    Amgen is expanding its footprint in India with an R&D center in Hyderabad, the latest by from the California company to boost its research facilities.
    fiercebiotech · 2d ago
  • Scribe’s Benjamin Oakes on a rare IPO and bringing CRISPR to the masses
    The CEO spoke with BioPharma Dive about convincing investors to buy into the first gene editing IPO in more than two years.
    biopharma_dive · 3d ago
  • Why Big Pharma is chasing the industry’s most-powerful supercomputer
    Bristol Myers Squibb is the latest major drugmaker to tap Nvidia for more computing power, betting that larger models and AI agents can speed drug discovery.
    biopharma_dive · 6d ago
  • STAT+: Pharmalittle: We’re reading about Replimune’s melanoma drug, a Medicare policy change, and more
    Eli Lilly and Novo Nordisk convinced a federal judge to toss an antitrust lawsuit by a compound pharmacy
    stat · 6d ago
view all news mentions →
identifiers
source
globaldata
top tags
Oncology8Type 2 Diabetes4NSCLC3Cardiology2IBD (Crohn's + UC)2
mentioned in
10news items
entity-linker matched
Data sources
openFDA
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?